We recommend you use the landscape mode of your smartphone

Our Experience

Our founders have spent 15 years running a successful industry-independent procurement consulting business.
With a proven track record, our combined experience adds up to over 100 consulting years, spent acquiring industry-specific knowledge and expertise in 15 European Countries. Now, we will apply these skills to the task of bringing about meaningful change in the procurement and distribution of medical devices.
  • We currently work in 15 European countries, for clients including 6 private equity investors
  • 100 combined years of consulting experience, and approx. 200 procurement projects undertaken in the last 15 years
  • Track record: > 20-60% permanent savings p.a.
  • Successful projects (highlights from the past 3 years):
  • 140 rehab, acute, and care locations - 40m € purchasing volume p.a.
  • 200 Pan-European private acute and outpatient locations - 120m € purchasing volume p.a
  • 40 acute clinics, 8000 beds – 120m € purchasing volume p.a.
  • 27 acute hospitals, 8000 beds - 300m € purchasing volume p.a (selected product groups)
  • 7 specialized acute hospitals, 20m € purchasing volume p.a
  • Lab Service Provider – 40 countries, 4 continents, 400m € purchasing volume p.a
  • > 20 Hospital & Healthcare Facilities, > 50m € purchasing volume
Our new business model is the next logical development step. Instead of standardizing and bundling medical devices to increase purchasing power for individual European Hospital Groups via traditional paper-based contracts, procurement can be done on a European scale by deploying our platform technology. This means that every participating European Hospital stands to make financial savings thanks to increased purchasing power, guided by the internet platform economy approach and rules.

Product range and risk classification for implants and medical consumables

The main focus of our platform is medical implants and consumables. In accordance with European Union Medical Device Regulations (MDR), they are grouped into 3 classes of risk classification:
Read more


Description of the risk


  • Particularly high methodological risk
  • For long-term drug delivery
  • Ingredients of animal origin and in the body
  • Direct application to the heart, central circulatory system or central nervous system and naturally invasive contraception
  • Cardiac catheters
  • Hip, knee or shoulder joints
  • Stents
  • Absorbable suture
  • Intrauterine pessary (Spiral)
  • Breast implant
  • Cardiac pacemaker
  • Increased methodological risk
  • System effects
  • Long-term applications
  • Non-invasive contraception
  • Long term ≥ 30 days, otherwise as with short term
  • Anaesthesia, respriration, radiation, dialysis, infusion equipment
  • Blood bags
  • Defibrillators
  • Contact lens cleaner
  • Dental implants
  • Application risk
  • Moderate invasiveness
  • Short-term applications in the body (e.g. the eye, intestinal, in surgically created body orifices)
  • For a short time ≤ 30 days, uninterrupted or repeated use of the same product
  • Dental materials
  • Disinfectants
  • Diagnostic ultrasound equipment
  • Disposable syringes
  • Contact lenses
  • PACS
  • Tracheal tubes
  • No methodological risks
  • Low invasiveness
  • No or uncritical skin contact
  • Temporary applications ≤ 60 minutes
  • Medical instruments
  • Walking aids, wheelchairs
  • Support stockings
  • Dressing materials
  • Reusable instruments
  • Surgical textiles

Over the last decade, we have turned our experience into a treasure trove, by creating the largest product and price database in Europe

See “What’s the price for my device” for a first analysis, free of charge.

Fact-based medical decision making tool

  • Use of the international German, Austrian, Swiss, French, Italian, Swedish, Norwegian, Danish, Finnish, British, Irish, Benelux, Portuguese, Polish and CEE Article and Price Database (> 10,000,000 single product data)
  • We supplement product information with more than 70 product features, to create 1:1 comparisons and “medical decision-making tools
  • This provides us with the same knowledge level as doctors, enabling us to enter discussions as equals, because:
    • We can ask the right questions
    • We can verify manufacturers' claims
    • We can prevent the wrong products from being used or we can prevent the levelling upwards.
  • Use of EU-compliant, manufacturer-neutral specifications for all tenders are available for all medical product groups

Benefits for our customers

  • Strengthening of own position
  • Organisation of supplier meetings
  • Derivation of the savings potential
  • 1:1 article comparisons are possible thanks to the creation of exact benchmarks
  • Creation of medical expert groups and EU-compliant tender specifications
  • Easy creation of '1:1 substitutions savings simulation’ / Financial savings through simple substitutions
  • There is no excuse for doctors to break off the discussion
  • Rapid creation of complete tenders possible
©2024 Innoloft GmbH